title: De novo tumors after orthotopic liver transplantation.
authors.affiliation: Department of General and Digestive Surgery and Abdominal Organ Transplantation, Hospital Universitario Doce de Octubre, Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Jiménez
authors.forename: D
authors.initials: D
authors.lastname: Rodríguez
authors.forename: E
authors.initials: E
authors.lastname: Marqués
authors.forename: C
authors.initials: C
authors.lastname: Loinaz
authors.forename: O
authors.initials: O
authors.lastname: Alonso
authors.forename: G
authors.initials: G
authors.lastname: Hernández-Vallejo
authors.forename: L
authors.initials: L
authors.lastname: Marín
authors.forename: F
authors.initials: F
authors.lastname: Rodríguez
authors.forename: I
authors.initials: I
authors.lastname: García
authors.forename: E
authors.initials: E
authors.lastname: Moreno
mesh_terms: D000293:Adolescent; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D008113:Liver Neoplasms / Q000453:epidemiology* / Q000401:mortality; D016031:Liver Transplantation / Q000401:mortality / Q000502:physiology; D008232:Lymphoproliferative Disorders / Q000188:drug therapy; D018579:Patient Selection; D011183:Postoperative Complications / Q000145:classification* / Q000188:drug therapy / Q000453:epidemiology; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents